Literature DB >> 22948346

[Medication in the elderly : cognitive impairment by drugs].

M Wehling1.   

Abstract

Cognitive impairment is a growing problem in aging societies, and dementia is turning into an epidemic. Modifiable conditions are of major interest, as a causal treatment of dementia is still unknown. Drugs represent a major reversible contributor to cognitive deficits and delirium which is seen in 12-50% of elderly in-hospital patients. A third of patients with delirium is being attributed to drugs, and age-related multimorbidity and subsequent polypharmacy are dominant risk factors. The anticholinergic mechanism is not sufficient to explain delirant drug side effects. Most prevalent in the induction of delirium are psychotropic drugs, in particular benzodiazepines, opiates, tricyclic antidepressants, and typical neuroleptics. In addition, "peripheral" drugs such as oxybutynin or fluorquinolones are involved. Rationalization of drug therapy is the clue for the prevention of cognitive impairment and delirium; most causative drugs are contained in negative lists (e.g., Beers list) and should be replaced by positively labelled drugs (e.g., by virtue of the FORTA classification). On top of the treatment of other modifiable causes for delirium (such as dehydration, infections, and fever), the avoidance or at least optimization of psychotropic drug prescriptions are key elements of the prevention of cognitive impairment in the elderly.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948346     DOI: 10.1007/s00108-012-3125-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  36 in total

1.  Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: A prospective study.

Authors:  Juho Uusvaara; Kaisu H Pitkala; Hannu Kautiainen; Reijo S Tilvis; Timo E Strandberg
Journal:  Drugs Aging       Date:  2011-02-01       Impact factor: 3.923

2.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

Authors:  Donna M Fick; James W Cooper; William E Wade; Jennifer L Waller; J Ross Maclean; Mark H Beers
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

3.  Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium.

Authors:  L Tune; S Carr; E Hoag; T Cooper
Journal:  Am J Psychiatry       Date:  1992-10       Impact factor: 18.112

4.  Anticholinergic activity of 107 medications commonly used by older adults.

Authors:  Marci L Chew; Benoit H Mulsant; Bruce G Pollock; Mark E Lehman; Andrew Greenspan; Ramy A Mahmoud; Margaret A Kirshner; Denise A Sorisio; Robert R Bies; Georges Gharabawi
Journal:  J Am Geriatr Soc       Date:  2008-05-26       Impact factor: 5.562

5.  Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases.

Authors:  M van den Akker; F Buntinx; J F Metsemakers; S Roos; J A Knottnerus
Journal:  J Clin Epidemiol       Date:  1998-05       Impact factor: 6.437

Review 6.  Occurrence and outcome of delirium in medical in-patients: a systematic literature review.

Authors:  Najma Siddiqi; Allan O House; John D Holmes
Journal:  Age Ageing       Date:  2006-04-28       Impact factor: 10.668

7.  Potentially inappropriate medications in the elderly: the PRISCUS list.

Authors:  Stefanie Holt; Sven Schmiedl; Petra A Thürmann
Journal:  Dtsch Arztebl Int       Date:  2010-08-09       Impact factor: 5.594

8.  Does delirium increase hospital stay?

Authors:  Jane McCusker; Martin G Cole; Nandini Dendukuri; Eric Belzile
Journal:  J Am Geriatr Soc       Date:  2003-11       Impact factor: 5.562

9.  Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study.

Authors:  Iacopo Cancelli; Gian Luigi Gigli; Antonella Piani; Barbara Zanchettin; Francesco Janes; Adriana Rinaldi; Mariarosaria Valente
Journal:  J Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.153

10.  Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study.

Authors:  T Sunderland; P N Tariot; R M Cohen; H Weingartner; E A Mueller; D L Murphy
Journal:  Arch Gen Psychiatry       Date:  1987-05
View more
  5 in total

Review 1.  Management of patients with risk factors.

Authors:  Frank Waldfahrer
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

2.  [Pain therapy in German long-term care facilities in a European comparison. Results of the SHELTER study].

Authors:  A Lukas; B Mayer; G Onder; R Bernabei; M D Denkinger
Journal:  Schmerz       Date:  2015-08       Impact factor: 1.107

Review 3.  Improving the health care of geriatric patients: management of urinary incontinence: a position paper.

Authors:  K Becher; M Oelke; B Grass-Kapanke; J Flohr; E A Mueller; U Papenkordt; B Schulte-Frei; K-C Steinwachs; S Süss; M Wehling
Journal:  Z Gerontol Geriatr       Date:  2013-07       Impact factor: 1.281

Review 4.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

5.  [Benzodiazepines in geriatrics].

Authors:  W Hofmann
Journal:  Z Gerontol Geriatr       Date:  2013-12       Impact factor: 1.281

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.